A cancer center and biotechnology enterprise are developing gene-edited therapies working in the gut to reduce adverse effects from cancer immunotherapies. . . . → Read More: Gene-Edited Treatments in Works for Safer Cancer Therapies
|
|||||
       
  |
A pharmaceutical company and developer of synthetic genomic materials are collaborating on discovery of therapeutic antibodies to treat a range of diseases. . . . → Read More: Pharma, Synthetic Bio Companies to Find Antibody Therapies 
An editorial published in more than 200 journals calls for governments worldwide to take immediate action to mitigate climate changes affecting public health. . . . → Read More: Health Journals Call for Emergency Climate Action  Comments are closed  Business conditions, Joint ventures/collaborations  biomedical, economics, energy, health care, life sciences, physical sciences 
Two developers of treatments and tools for neurological diseases are developing a system for early detection of agitation, a symptom of psychiatric disorders. . . . → Read More: Biotechs Partner on Agitation Detection Technology One comment - (Comments are closed) Intellectual property, Joint ventures/collaborations biomedical, biotechnology, engineering, life sciences, mathematics, medical device, patent, physical sciences, psychiatric, software 
Results show a synthetic antibody reduces the rate of cognitive decline, one of two measures in a clinical trial of patients with mild to moderate Alzheimer’s disease. . . . → Read More: Trial Shows Synthetic Antibody Slows Cognitive Decline One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, biotechnology, chemistry, clinical trials, Europe, life sciences, pharmaceuticals, physical sciences 
Two biotechnology companies are designing new processes to produce ingredients much like those found in drugs made from plants for essential medicines. . . . → Read More: Biotechs Partner on Synthetic Plant-Based Drugs One comment - (Comments are closed) Joint ventures/collaborations biomedical, biotechnology, engineering, entrepreneurs, genomics, health care, life sciences, manufacturing, mathematics, pharmaceuticals, university 
The biotechnology company Moderna Inc. agreed to build a manufacturing plant for its messenger RNA or mRNA vaccines in Canada. . . . → Read More: Moderna to Build mRNA Vaccine Plant in Canada One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, biotechnology, Canada, Covid-19, genomics, life sciences, manufacturing, pharmaceuticals 
Drug maker Sanofi is purchasing biotechnology company Translate Bio, a developer of messenger RNA vaccines and therapies, and a long-time collaborator. . . . → Read More: Sanofi Acquires mRNA Developer in $3.2B Deal One comment - (Comments are closed) Finance, Joint ventures/collaborations biomedical, biotechnology, clinical trials, Covid-19, equity, Europe, genomics, investment, life sciences, merger, pharmaceuticals 
A French biopharmaceutical company is gaining access to a technology using synthetic nucleic acids to treat rare genetic neurological diseases. . . . → Read More: Pharma Gains Synthetic DNA for Rare Diseases in $1B+ Deal One comment - (Comments are closed) Intellectual property, Joint ventures/collaborations biomedical, biotechnology, engineering, Europe, genomics, licensing, life sciences, nanotechnology, pharmaceuticals, university 
A biotechnology enterprise is teaming with a pharmaceutical company to develop off-the-shelf therapies for malfunctioning mitochondria, energy centers of cells. . . . → Read More: Pharma, Biotech Partner on Off-the-Shelf Cell Therapies Comments are closed Intellectual property, Joint ventures/collaborations, New products Asia, biomedical, biotechnology, entrepreneurs, genomics, Israel, Japan, licensing, life sciences, pharmaceuticals, stem cells |
|
|||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
